5.70
0.21 (3.83%)
| Previous Close | 5.49 |
| Open | 5.70 |
| Volume | 225 |
| Avg. Volume (3M) | 3,349 |
| Market Cap | 154,381,648 |
| Price / Sales | 0.090 |
| 52 Weeks Range |
| Diluted EPS (TTM) | -1.69 |
| Quarterly Revenue Growth (YOY) | 37.80% |
| Total Debt/Equity (MRQ) | 280.27% |
| Current Ratio (MRQ) | 1.32 |
| Operating Cash Flow (TTM) | -4.64 M |
| Levered Free Cash Flow (TTM) | 32.74 M |
| Return on Assets (TTM) | -6.11% |
| Return on Equity (TTM) | -65.10% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Bearish | Mixed |
| Medical Care Facilities (Global) | Bearish | Mixed | |
| Stock | American Oncology Network, Inc. | - | - |
AIStockmoo Score
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | -3.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | -0.75 |
|
American Oncology Network Inc is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. The company pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. It is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| % Held by Insiders | 18.80% |
| % Held by Institutions | 0.10% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Diversified Trust Co | 31 Dec 2024 | 27,101 |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 07 Jan 2025 | Announcement | Fort Wayne Medical Oncology and Hematology Joins American Oncology Network |
| 02 Jan 2025 | Announcement | Cancer and Blood Specialists of Arizona and American Oncology Network Welcome Dr. Ronak Rakesh Shah |
| 30 Dec 2024 | Announcement | Hematology Oncology of Indiana Physician Research Presented at 66th ASH Annual Meeting |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |